PRAX-222 - Initial Dose
PRAX-222-111
Phase 2 small_molecule active
Quick answer
PRAX-222 - Initial Dose for SCN2A-DEE is a Phase 2 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- SCN2A-DEE
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active